Skip to main content

Table 1 Educational objectives of the group sessions in the intervention group of the THERAD study

From: Study protocol: Randomised controlled trial to evaluate the impact of an educational programme on Alzheimer’s disease patients’ quality of life

Session 1 (S1): knowledge of the disease - To identify the cognitive impairment of the patient in everyday life
- To recognise the remaining functional abilities
- To determine the nonpharmacological measures to be implemented
Session 2 (S2): pharmacological and nonpharmacological treatments. Behavioural and psychological symptoms of dementia - To understand the potential effect of pharmacological therapies
- To identify behavioural and psychological symptoms of the disease
- To implement nonpharmacological measures to prevent these symptoms
Session 3 (S3): crisis situations. Prevention of caregiver’s exhaustion - To identify conditions of high risk (treatment modification, concomitant illness, change of environment, relocation)
- To recognise and prevent caregiver’s burnout
- To identify their resources
Session 4 (S4): assistive devices and care pathways - To understand assistive devices, respite and legal aspects raised by the disease
- To identify the resources available in crisis or emergency situations (general practitioner, specialist consultation, hospitalisation)
  1. THERAD, Therapeutic Education in Alzheimer’s Disease.